A Cost-Effectiveness Analyses of Using Sunitinib (SU) in First Line of Metastatic Renal Cancer in Romanian Jurisdiction
Abstract
Authors
F. Berghea J. Skoupa T. Ciuleanu L. Miron D.L. Stanculeanu D. Jinga M. Dediu D.N. Mateescu P. Hájek B. Bradatan J. Xuan